Patients with Fanconi anemia subgroup D1, attributable to biallelic mutations in BRCA2, have an increased risk of solid tumors. Tumors in the kidneys of these patients are almost exclusively Wilms tumor. We report the first recorded case, to our knowledge, of a Clear Cell Sarcoma of the Kidney in a patient with this cancer predisposition syndrome. We review different aspects of the need for careful clinical observation in patients of this complementation group, given their risk for malignancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2350/14-03-1450-CR.1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!